News

Article

The Invitation from Breast Cancer

Author(s):

Sharon Murphy

A two-time breast cancer survivor, I danced above the invitation it first offered me.

Image of a woman crossing her hands over her left breast.

The Invitation

On a stifling, hot summer day

The invitation arrived…

not in a gold embossed envelope,

no RSVP enclosed.

It came with words so numbing,

They tumble down at lightning speed

so fast my brain wouldn’t repeat them,

Couldn’t repeat them…

“You have cancer.”

I learn to dance with you

‘til I fall dazed, dizzy with choices.

I research. I listen. I choose.

In the end, I dance above you.

My wisdom, my strength, my courage

Command you to know.

I am still here.

This post was written and submitted by Sharon Murphy. The article reflects the views of Murphy and not of CURE®. This is also not supposed to be intended as medical advice.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of woman with blonde hair.
Image of woman with brown hair.
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
a man and a woman in separate boxes in front of a dark blue background
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Related Content
Image of woman with pink robbon.
March 11th 2025

Vepdegestrant May Reduce Disease Progression in Breast Cancer Subset

Spencer Feldman
Vepdegestrant improved progression-free survival in patients with estrogen receptor 1 mutations in advanced ER-positive, HER2-negative breast cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of woman holding her chest.
March 7th 2025

BRCA1/2 Mutations May Associate With Better Chemo Response in TNBC

Alex Biese
Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in patients with BRCA1/2 mutations.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of woman holding pink ribbon.
March 4th 2025

Verzenio Combo May Improve Survival in HR+/HER2– Advanced Breast Cancer

Spencer Feldman
Verzenio plus Faslodex improved progression-free survival in HR+/HER2– advanced breast cancer after CDK/6i failure, with a manageable safety profile.
Illustration of woman with brown hair.
March 4th 2025

Breast Cancer And Depending On The Kindness Of Strangers

Laura Yeager
I reflect on my unexpected bond with a neighbor during my breast cancer treatment, finding comfort in his company when I needed someone to talk to.